RARRES1 is enriched in glioblastoma multiforme (GBM), particularly WHO grade-IV cases; and high expression of RARRES1 is a predictor of poor prognosis, indicating that it may participate in GBM pathogenesis, and is a potential therapeutic target in this context [22]. The gene discussed is RARRES1; the disease is glioblastoma.